
VCs Invest $5.8 Billion in Bio-based Chemicals, as Focus Shifts to Disruptive Synthetic Biology
This year, synthetic biology startups have raised 53% of all VC funding in bio-based materials and chemicals, as venture firms flock to technology platforms such as DNA synthesis-as-a-service.